NIMH Chemical Synthesis and Drug Supply Program

Compound Information Page

Compound Name: 2-(3-Amino-4-iodophenoxy)methylimidazoline Dihydrochloride
NIMH Code: I-707
Alternative Name:
Abbreviation: AMIPI
Indications: Imidazoline-guaninidine binding site (IGRS) ligand
Package Sizes:
References: R. Raddatz, A. Parini and S. M. Lanier, Localization of the imidazoline binding domain on monoamine oxidase B, Mol. Pharmacol., 52, 549-553 (1997); B. Ivkovic, V. Bakthavachalam, W. Zhang, A. Parini, D. Diz, S. Bosch, J. L. Neumeyer and S. M. Lanier, Development of a high-affinity radioiodinated ligand for identification of imidazoline/guanidinium receptive sites (IGRS): intratissue distribution of IGRS in liver, forebrain, and kidney, Mol. Pharmacol., 46, 15-23 (1994).
CAS:
Molecular Formula: C10H14Cl2IN3O
HBA: 4
HBD: 2
RotB: 3
PubChemID:
AlogP: 1.4983
TPSA: 59.64
Activity:
Comments:
Last Updated 2006-09-22 01:13 PM
Structure of I-707
About The Program

Since 1959, the NIMH Chemical Synthesis and Drug Supply Program has synthesized and distributed novel research chemicals, psychoactive drugs, and compounds that are unavailable from commercial sources to the scientific community working on research relevant to mental health.

Content © 2014. «RTI International».